Page last updated: 2024-08-23

substance p and cefepime

substance p has been researched along with cefepime in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arlet, G; Ašmonienė, V; Giedraitienė, A; Pavilonis, A; Plančiūnienė, R; Simonytė, S; Vitkauskienė, A1
Chu, X; Guo, YY; Liu, QZ; Shen, LM; Wang, J; Zhang, CL1

Other Studies

2 other study(ies) available for substance p and cefepime

ArticleYear
CTX-M-producing Escherichia coli in Lithuania: associations between sites of infection, coresistance, and phylogenetic groups.
    Medicina (Kaunas, Lithuania), 2013, Volume: 49, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Galanin; Gentamicins; Humans; Lithuania; Phylogeny; Substance P

2013
Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China.
    BMC infectious diseases, 2014, May-15, Volume: 14

    Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; China; Ciprofloxacin; Dysentery, Bacillary; Female; Galanin; Genes, Bacterial; Genotype; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Shigella; Substance P; Virulence

2014